Ambisome 50 mg injection
PDF Leaflet Revision Date: 20 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Empirical treatment of presumed fungal infection and severe systemic mycoses.
Dosage (summary)
3-5 mg/kg/day for systemic infections; 5-10 mg/kg for mucormycosis.
Special Populations
- Paediatric patients
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Use only if benefits outweigh risks; safety in breastfeeding not established.
Key Drug Interactions
- Nephrotoxic medications
- Corticosteroids
- Digitalis glycosides
Contraindications
- Hypersensitivity to constituents
Common side effects
- Fever
- Chills
- Hypokalaemia
- Headache
Counselling Points
- Monitor for infusion reactions
- Avoid during dialysis
- Contains sucrose
Serious warnings
- Anaphylaxis
- Infusion-related reactions
- Renal toxicity
Important Disclaimer
The Ambisome 50 mg injection professional information leaflet below is the property of Key Oncologics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
